{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:43:33Z","timestamp":1791477813285,"version":"4.3.4"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH015"],"award-info":[{"award-number":["ZR2023MH015"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>We summarized the clinical manifestations, auxiliary examinations, treatment, and prognostic characteristics of a patient with neurexin-3a IgG-mediated autoimmune encephalitis. On March 2, 2024, a 43-year-old male patient was admitted to the Second Hospital of Shandong University and had prodromal symptoms of infection before the onset of encephalitis. The main manifestations were episodic loss of consciousness, eyes turned upward to the right, clenched teeth, bleeding from tongue bite, and limb twitching. Imaging results showed that the left frontal lobe was characterized by a patchy, slightly longer T1 and T2 signal foci, with a slightly higher signal in the pressurized water image. The CSF virus test was normal; both the serum and CSF were positive for neurexin-3a antibodies using CBA, which were confirmed by TBA. The patient\u2019s symptoms improved after glucocorticosteroid therapy. Neurexin-3a IgG-mediated autoimmune encephalitis is a new type of autoimmune encephalitis, and suspicion of associated disease requires further testing for neurexin-3a IgG for a definitive diagnosis.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1542578","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:13:18Z","timestamp":1747800798000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Neurexin-3a IgG-mediated autoimmune encephalitis: a case report and literature review"],"prefix":"10.3389","volume":"16","author":[{"given":"Pin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-mediated encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577824","article-title":"Autoimmune encephalitis: suspicion in clinical practice and mimics","volume":"365","author":"Costa","year":"2022","journal-title":"J Neuroimmunol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002775","article-title":"Human neurexin-3\u03b1 antibodies associate with encephalitis and alter synapse development","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0896-6273(95)90306-2","article-title":"Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons","volume":"14","author":"Ullrich","year":"1995","journal-title":"Neuron."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.11.025","article-title":"Rare deletions at the neurexin 3 locus in autism spectrum disorder","volume":"90","author":"Vaags","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308626100","article-title":"Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins","volume":"101","author":"Kattenstroth","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002781","article-title":"Neurexin-3\u03b1: A new antibody target in autoimmune encephalitis","volume":"86","author":"Waters","year":"2016","journal-title":"Neurology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1212\/NXI.0000000000000392","article-title":"Postmalaria neurologic syndrome associated with neurexin-3\u03b1 antibodies","volume":"4","author":"Costa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11060673","article-title":"Mild amnestic cognitive impairment and depressive symptoms in autoimmune encephalitis associated with serum anti-neurexin-3\u03b1 Autoantibodies","volume":"11","author":"Hansen","year":"2021","journal-title":"Brain Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14481","article-title":"Neurexin-3\u03b1-associated autoimmune encephalitis: a case report of full recovery after rituximab therapy","volume":"27","author":"Loehrer","year":"2020","journal-title":"Eur J Neurol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn113694-20201010-00770","article-title":"Neurexin-3\u03b1 IgG mediated autoimmune encephalitis: acase report13","volume":"54","author":"Zhang","year":"2021","journal-title":"Chin J Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3760\/cma.j.cn113694-20211219-00899","article-title":"Anti-neurexin-3\u03b1 antibody-associated encephalitis with parkinsonism as the main manifestation: acase report","volume":"55","author":"Zheng","year":"2022","journal-title":"Chin J Neurol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577548","article-title":"Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases","volume":"355","author":"Guedes","year":"2021","journal-title":"J Neuroimmunol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-06054-7","article-title":"Neurexin-3\u03b1-associated autoimmune encephalitis with intracranial diffuse large B lymphoma diagnosed on FDG and TSPO PET\/MRI","volume":"50","author":"Zhang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1060110","article-title":"Case report: Anti-neurexin-3\u03b1-associated autoimmune encephalitis secondary to contrast-induced encephalopathy","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Neurol"},{"key":"B17","article-title":"Refractory status epilepticus secondary to Neurexin-3a encephalitis: A case report","volume":"23","author":"Koh","year":"2018","journal-title":"Neurol Asia"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1212\/NXI.0000000000000392","article-title":"Postmalaria neurologic syndrome associated with neurexin-3\u03b1 antibodies","volume":"4","author":"Costa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/10408363.2023.2247482","article-title":"General features, pathogenesis, and laboratory diagnostics of autoimmune encephalitis","volume":"61","author":"Masciocchi","year":"2024","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.ccc.2021.11.007","article-title":"Autoimmune encephalitis: distinguishing features and specific therapies","volume":"38","author":"Co","year":"2022","journal-title":"Crit Care Clin"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1542578\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T04:13:21Z","timestamp":1747800801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1542578\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2025.1542578"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1542578","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"article-number":"1542578"}}